Literature DB >> 28942870

Impact of atrial arrhythmias on outcome in adults with congenital heart disease.

H Yang1, J M Kuijpers1, J R de Groot2, T C Konings3, A van Dijk4, G Tj Sieswerda5, M C Post6, B J M Mulder1, B J Bouma7.   

Abstract

BACKGROUND: Adults with congenital heart disease (ACHD) are affected by atrial arrhythmias (AA). To elucidate the impact of AA on prognosis, we aimed to determine the impact of AA on death, heart failure and stroke in ACHD patients in a prospective nationwide clinical registry.
METHODS: All patients aged ≥18years included in the CONCOR registry per October 1st 2015 were analysed. Prior AA was defined as atrial fibrillation, atrial flutter or unspecified AA before inclusion in CONCOR and new-onset AA as a first documented AA during follow-up. The outcomes were death, first stroke and first admission for heart failure (HF).
RESULTS: The study cohort comprised 14,224 patients (baseline median age 33.6 [IQR 23-47], male 49.5%, AA n=1501, complex defect 10.3%, repaired defect 58.9%). Median follow-up was 6.5years [IQR 3-10]. Adjusting for age, sex, repair status and defect severity, patients with prior AA had higher mortality and more HF admissions, but no increased risk of stroke compared to those without AA (HR=2.11; 95% CI=1.79-2.49; p<0.001, HR=4.06; 95% CI=2.66-6.19; p<0.001 and HR=1.09; 95% CI=0.71-1.68; p=0.698, respectively). New-onset AA during follow-up was significantly associated with stroke (HR=2.04; 95% CI=1.05-3.96; p=0.036).
CONCLUSIONS: ACHD patients with prior AA have a 2-fold increased risk of death and a 4-fold increased risk of heart failure, but no increased risk for stroke compared to those without AA. Defect severity and age appear to be more important risk factors for stroke than prior AA. Stroke risk is increased only after conversion of new onset AA.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial arrhythmias; Congenital heart disease; Heart failure; Mortality; Prognosis; Stroke

Mesh:

Year:  2017        PMID: 28942870     DOI: 10.1016/j.ijcard.2017.06.073

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

Review 1.  Therapy of supraventricular and ventricular arrhythmias in adults with congenital heart disease-narrative review.

Authors:  Kristina Wasmer; Lars Eckardt; Helmut Baumgartner; Julia Köbe
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

2.  Impact of Atrial Fibrillation on Survival in Adults with Congenital Heart Disease: a Retrospective Population-based Study.

Authors:  Shin Yi Jang; June Huh; Eun Kyoung Kim; Sung A Chang; Jinyoung Song; I Seok Kang; Seung Woo Park
Journal:  J Korean Med Sci       Date:  2021-02-01       Impact factor: 2.153

3.  Arrhythmias in adults with congenital heart disease and heart failure.

Authors:  Francis Bessière; Blandine Mondésert; Marie-A Chaix; Paul Khairy
Journal:  Heart Rhythm O2       Date:  2021-12-17

4.  The Adult Congenital Heart Disease Anatomic and Physiological Classification: Associations with Clinical Outcomes in Patients with Atrial Arrhythmias.

Authors:  Anastasios Kartas; Andreas S Papazoglou; Diamantis Kosmidis; Dimitrios V Moysidis; Amalia Baroutidou; Ioannis Doundoulakis; Stefanos Despotopoulos; Elena Vrana; Athanasios Koutsakis; Georgios P Rampidis; Despoina Ntiloudi; Sotiria Liori; Tereza Mousiama; Dimosthenis Avramidis; Sotiria Apostolopoulou; Alexandra Frogoudaki; Afrodite Tzifa; Haralambos Karvounis; George Giannakoulas
Journal:  Diagnostics (Basel)       Date:  2022-02-11

5.  Force Trends and Pulsatility for Catheter Contact Identification in Intracardiac Electrograms during Arrhythmia Ablation.

Authors:  David Rivas-Lalaleo; Sergio Muñoz-Romero; Mónica Huerta; Mayra Erazo-Rodas; Juan José Sánchez-Muñoz; José Luis Rojo-Álvarez; Arcadi García-Alberola
Journal:  Sensors (Basel)       Date:  2018-05-02       Impact factor: 3.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.